Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 29687 | 148 | 27.1 | 51% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BENZHYDRYLPIPERAZINE | Author keyword | 4 | 75% | 2% | 3 |
| 2 | 1 BENZHYDRYL PIPERAZINE | Author keyword | 3 | 100% | 2% | 3 |
| 3 | 1 BENZHYDRYL PIPERAZINE DERIVATIVES | Author keyword | 2 | 67% | 1% | 2 |
| 4 | DISTORTED TETRAHEDRON | Author keyword | 2 | 50% | 2% | 3 |
| 5 | MOL BIOL GENETBILGEN | Address | 1 | 100% | 1% | 2 |
| 6 | TETRAHEDRAL CONFIGURATION | Author keyword | 1 | 40% | 1% | 2 |
| 7 | MOL SCI INFORMAT | Address | 1 | 27% | 2% | 3 |
| 8 | CLOCINIZINE | Author keyword | 1 | 50% | 1% | 1 |
| 9 | DELTA SARCOGLYCAN SG | Author keyword | 1 | 50% | 1% | 1 |
| 10 | ENTEROVIRUS INHIBITOR | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NCO 700 | 11 | 100% | 4% | 6 |
| 2 | POTENT JAK3 INHIBITORS | 1 | 50% | 1% | 1 |
| 3 | PIPERAZINE DERIVATIVES | 1 | 11% | 3% | 5 |
| 4 | MOLECULE INHIBITOR | 0 | 33% | 1% | 1 |
| 5 | CARCINOMA IN VITRO | 0 | 12% | 2% | 3 |
| 6 | PROSTACYCLIN ANALOG CICAPROST | 0 | 25% | 1% | 1 |
| 7 | ALPHA ISOACTIN | 0 | 20% | 1% | 1 |
| 8 | ALPHA N CARBAMOYLALKYLCUPRATE CHEMISTRY | 0 | 20% | 1% | 1 |
| 9 | BETA LIGANDS | 0 | 17% | 1% | 1 |
| 10 | BISMUTH OXIDE NANOPARTICLES | 0 | 17% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| A novel paradigm for therapeutic basis of advanced heart failure - assessment by gene therapy | 2005 | 6 | 75 | 11% |
| PROTEOLYTIC-ENZYMES AND THEIR INHIBITORS IN BRONCHOPULMONARY DISEASES | 1985 | 1 | 3 | 33% |
| PROTEOLYTIC-ENZYMES AND ENHANCED MUSCLE PROTEIN BREAKDOWN | 1984 | 1 | 19 | 5% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOL BIOL GENETBILGEN | 1 | 100% | 1.4% | 2 |
| 2 | MOL SCI INFORMAT | 1 | 27% | 2.0% | 3 |
| 3 | JSS | 1 | 50% | 0.7% | 1 |
| 4 | GENOM ONCOL PROGRAMME | 1 | 29% | 1.4% | 2 |
| 5 | DOS PL BOT BIOTECHNOL | 0 | 20% | 0.7% | 1 |
| 6 | PATHOPHYSIOL INTERNAL MED | 0 | 14% | 0.7% | 1 |
| 7 | INTERNAL MED ORGANOL PATHOL CARDIOVASC | 0 | 100% | 0.7% | 1 |
| 8 | ORGAN PATHOL INTERNAL MED | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000116812 | BENZOYLOXY BENZOPHENONE//POST STUDIES BIOTECHNOL BIOINFO//YUVARAJA |
| 2 | 0.0000113968 | META LEVEL INFERENCE//P TOLUENE SULFONYL CHLORIDE//CEREBRAL VASODILATOR |
| 3 | 0.0000108877 | IRSOGLADINE MALEATE//SAM HIGGINBOTTOM AGR TECHNOL SCI//IRSOGLADINE |
| 4 | 0.0000102808 | DEPARMENT CHEM CHEM ENGN//TETARAAZAMACROCYCLE//TETRAAZAMACROCYCLE |
| 5 | 0.0000098194 | GLYCOCONJUGATED PORPHYRINS//GLYCOCONJUGATED PORPHYRIN//GLYCOSYLATED PORPHYRINS |
| 6 | 0.0000097810 | 1 31 6 BETA D GLUCAN//FUCUS EVANESCENS//MEDICINAL PLANT RESEARCH |
| 7 | 0.0000093078 | FIBRINOGEN THROMBIN CLOTTING//FIBRIN ALPHA CHAIN//COLLAGEN RELATED SYNTHETIC PEPTIDE |
| 8 | 0.0000063883 | UTERINE AGGLUTININ//SIALIC ACID BINDING PROTEIN//MERCAPTOMETHYLIMIDAZOLE AND GASTRIC ACID SECRETION |
| 9 | 0.0000063685 | BUDIPINE//4 SUBSTITUTED ANILINES//LONG TERM ELECTROMYOGRAPHY |
| 10 | 0.0000063642 | OPTICALLY ACTIVE ANTIFUNGAL AZOLE//BIOORGAN MED CHEM//CS 758 |